Table 2.
Characteristic | Total (%) (n = 35) |
A IBR 280 VEN 200 (n = 2) |
B IBR 420 VEN 200 (n = 16) |
C IBR 280 VEN 400 (n = 8) |
D IBR 560 VEN 200 (n = 4) |
E IBR 420 VEN 400 (n = 5) |
---|---|---|---|---|---|---|
Mean age in years (min-max) | 63 (49-82) | 75 (69-82) | 62 (54-76) | 66 (49-79) | 62 (53-68) | 56 (50-60) |
% male | 29 (83%) | 2 (100%) | 14 (87%) | 6 (75%) | 3 (75%) | 4 (80%) |
Prior auto transplant (yes), % | 15 (43%) | 0 (0%) | 8 (50%) | 4 (50%) | 1 (25%) | 2 (40%) |
Refractory to last line of therapy (yes), % | 18 (51%) | 2 (100%) | 5 (31%) | 4 (50%) | 3 (75%) | 4 (80%) |
Lines of prior Rx | ||||||
1 line | 20 (57%) | 1 (50%) | 12 (75%) | 3 (38%) | 3 (75%) | 1 (20%) |
2 lines | 13 (37%) | 1 (50%) | 4 (25%) | 3 (38%) | 1 (25%) | 4 (80%) |
3 lines | 2 (6%) | 0 (0%) | 0 (0%) | 2 (25%) | 0 (0%) | 0 (0%) |
Stage at enrollment | ||||||
1-2 | 2 (6%) | 0 (0%) | 1 (6%) | 0 (0%) | 1 (25%) | 0 (0%) |
3 | 6 (17%) | 1 (50%) | 2 (13%) | 1 (13%) | 1 (25%) | 1 (20%) |
4 | 27 (77%) | 1 (50%) | 13 (81%) | 7 (88%) | 2 (50%) | 4 (80%) |
MIPI at enrollment | ||||||
Low | 17 (49%) | 1 (50%) | 9 (56%) | 2 (25%) | 2 (50%) | 3 (60%) |
Intermediate | 12 (34%) | 1 (50%) | 5 (31%) | 2 (25%) | 2 (50%) | 2 (40%) |
High | 6 (17%) | 0 (0%) | 2 (13%) | 4 (50%) | 0 (0%) | 0 (0%) |